Esomeprazole sodium

Related records

Trials (350)

• 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
• 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)
• 15-day Sequential Therapy for Helicobacter Pylori Infection in Korea
• 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection
• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
• A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
• A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain
• A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole
• A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy
• A Healthy Female and Male Volunteers Aspirin Study
• A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding
• A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis
• A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)
• A Multiple Dose Study of LY3502970 in Healthy Participants
• A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
• A Phase 1 Study of Tegoprazan on Healthy Male Volunteers
• A Phase I Study of LX22001 for Injection in Healthy Subjects
• A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
• A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

Approved for (2)

• Duodenal ulcer
• Gastroesophageal reflux disease

In development for (1)

• Peptic ulcer disease Phase 1

Targets (2)

• ATP4A Potassium-transporting ATPase inhibitor
• ATP4B Potassium-transporting ATPase inhibitor